Abciximab (ReoPro)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Abciximab (ReoPro), covering 2011-10-27 to 2012-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Anti-inflammatory Effects of Intracoronary and Intravenous Abciximab Administration During Primary Percutaneous Coronary Intervention [Phase 4]